<SEC-DOCUMENT>0001140361-23-019398-index.html : 20230420 <SEC-HEADER>0001140361-23-019398.hdr.sgml : 20230420 <ACCEPTANCE-DATETIME>20230420163041 ACCESSION NUMBER: 0001140361-23-019398 CONFORMED SUBMISSION TYPE: PRE 14A PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20230616 FILED AS OF DATE: 20230420 DATE AS OF CHANGE: 20230420 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eterna Therapeutics Inc. CENTRAL INDEX KEY: 0000748592 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 311103425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: PRE 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-11460 FILM NUMBER: 23833519 BUSINESS ADDRESS: STREET 1: 1035 CAMBRIDGE STREET STREET 2: SUITE 18A CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: (212) 582-1199 MAIL ADDRESS: STREET 1: 10531 4S COMMONS DRIVE STREET 2: SUITE 166-550 CITY: SAN DIEGO STATE: CA ZIP: 92127 FORMER COMPANY: FORMER CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc. DATE OF NAME CHANGE: 20210325 FORMER COMPANY: FORMER CONFORMED NAME: NTN BUZZTIME INC DATE OF NAME CHANGE: 20051230 FORMER COMPANY: FORMER CONFORMED NAME: NTN COMMUNICATIONS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>PRE 14A <SEQUENCE>1 <FILENAME>ny20008400x1_pre14a.htm <DESCRIPTION>PRE 14A <TEXT> Document 1 - file: ny20008400x1_pre14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>ny20008400x1_pc01.jpg <TEXT> Document 2 - file: ny20008400x1_pc01.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>ny20008400x1_pc02.jpg <TEXT> Document 3 - file: ny20008400x1_pc02.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>ny20008400x1_pvp01x1.jpg <TEXT> Document 4 - file: ny20008400x1_pvp01x1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>ny20008400x1_pvp02.jpg <TEXT> Document 5 - file: ny20008400x1_pvp02.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>ny20008400x1_pvp03x1.jpg <TEXT> Document 6 - file: ny20008400x1_pvp03x1.jpg
</DOCUMENT> </SEC-DOCUMENT>